Invention Application
- Patent Title: IMPROVED COMPLEMENT RECEPTOR 2 (CR2) TARGETING GROUPS
- Patent Title (中): 改进补充受体2(CR2)目标群体
-
Application No.: PCT/US2011/036552Application Date: 2011-05-13
-
Publication No.: WO2011143637A1Publication Date: 2011-11-17
- Inventor: KOVACS, James , HANNAN, Jonathan P. , HOLERS, V. Michael
- Applicant: THE REGENTS OF THE UNIVERSITY OF COLORADO, a Body Corporate , KOVACS, James , HANNAN, Jonathan P. , HOLERS, V. Michael
- Applicant Address: 1800 Grant Street, 8th Floor Denver, CO 80203 US
- Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, a Body Corporate,KOVACS, James,HANNAN, Jonathan P.,HOLERS, V. Michael
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, a Body Corporate,KOVACS, James,HANNAN, Jonathan P.,HOLERS, V. Michael
- Current Assignee Address: 1800 Grant Street, 8th Floor Denver, CO 80203 US
- Agency: SHOW, Matthew, D. et al.
- Priority: US61/345,035 20100514
- Main IPC: C07K14/705
- IPC: C07K14/705 ; C07K19/00
Abstract:
Provided herein are compositions and methods directed to soluble proteins which can selectively deliver modulators of complement activity. Targeted delivery of these modulators is accomplished by selectively mutating particular amino acids in a targeting protein portion of the composition corresponding to at least the first two N-terminal SCR domains of CR2. Depending on the particular combination of mutations introduced into the targeting portion, a complement activity modulator can be selectively delivered to particular ligands of CR2 at sites where complement system activation or suppression is desired.
Information query